Effects of S1 protein and exposure duration on co-cultures of HPAEpics and AMs. by Yanru Liu (1662463)

The interaction effect of CS*SFSF on fluctuations in Pak choi biomass under cycling irrigation (CI) paired with Si fertilization. by Jieru Zhao (21262027)

The interaction effect of CS*SFSF on enzyme Activity Fluctuations in Leaves under cycling irrigation (CI) combined with Si fertilization. by Jieru Zhao (21262027)

The interaction effect of CS*SFSF on Chlorophyll levels subjected to varied cycling irrigation (CI) modes coupled with silicon supplementation. by Jieru Zhao (21262027)

The interaction effect of CS*SFSF on Changes in soil pH (a), potassium to sodium ratio (K/Na) (b), ESP (c), and SAR (d) under cycling irrigation (CI) coupled with silicon fertiliza... by Jieru Zhao (21262027)

The interaction effect of CS*SFSF on fluctuations in silicon content within soil and leaf under cycling irrigation (CI) coupled with Si fertilization. by Jieru Zhao (21262027)

The interaction effect of CS*SFSF on soil ion content under cycling irrigation (CI) combined with Si fertilization. by Jieru Zhao (21262027)

The interaction effect of CS*SFSF on alterations in leaf Malondialdehyde (MDA) and soluble protein levels subjected to cycling irrigation (CI) methods in conjunction with silicon n... by Jieru Zhao (21262027)

The interaction effect of CS*SFSF on SOM and WDPT under cycling irrigation (CI) coupled with Si fertilization. by Jieru Zhao (21262027)

Unsupervised clustering of TCGA-KIRC subjects based on glucocorticoid signaling-related genes. by Yu Zhang (12946)

Top predictive variables for KDIGO stage ≥ 3 identified by the final Random Forest model. by Julian Müller-Kühnle (22265248)

Effects of compound 4f on neuroinflammation in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Pharmacokinetics and pharmacodynamics of compound 4f in mice. by Naoto Arimura (416442)

Adverse event list. by Stefan Halbherr (21353882)

“…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”

Patient characteristics. by Stefan Halbherr (21353882)

“…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”

Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Effects of compound 4f on the seizure-like response elicited by kainic acid (KA). by Naoto Arimura (416442)

The effects of cannabinoid receptor antagonists against neuroprotective effects of compound 4f in KA-treated mice. by Naoto Arimura (416442)

Effects of compound 4f on neuronal cell loss in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

CRISPRi interrogation of the <i>Sox10</i> ECs. by Hongjoo An (21703199)